|
End-of-day quote
Bratislava S.E.
2026-08-20
|
5-day change | 1st Jan Change | ||
| 31.00 EUR | -.--% |
|
-.--% | +3.33% |
| 03-16 | Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet | RE |
| 02-23 | Zentiva as responds to EU court decision on UWWTD | RE |
| Market Cap | 243M 212M 200M 181M 340M 23.3B 341M 2.39B 923M 11.85B 913M 893M 38.12B | P/E 2017 |
7.27x | P/E 2018 | 177x |
|---|---|---|---|---|---|
| Enterprise Value | 242M 211M 199M 181M 339M 23.23B 340M 2.38B 920M 11.81B 910M 890M 38B | EV / Sales 2017 |
3.97x | EV / Sales 2018 | 11.2x |
| Free-Float |
4.05% | Yield 2017 |
13.8% | Yield 2018 | - |
| 6 months | +3.33% | ||
| Current year | +3.33% |
| 1 month | 31 | 31 | |
| Current year | 29 | 33 | |
| 1 year | 29 | 45 | |
| 3 years | 24 | 45 | |
| 5 years | 24 | 45 | |
| 10 years | 11 | 370 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2015-11-11 | |
| Corporate Officer/Principal | - | 2022-08-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Mojmír Krutý
BRD | Director/Board Member | - | 2013-07-07 |
Martin Albert
BRD | Director/Board Member | - | 2018-10-17 |
Kenneth Lynard
BRD | Director/Board Member | 58 | 2020-11-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -31.11% | +3.33% | 57.6M | ||
| -1.61% | -0.15% | +11.45% | +60.09% | 45.94B | ||
| -1.02% | -1.90% | +35.99% | +100.50% | 37.22B | ||
| +2.19% | +3.65% | +10.70% | +80.29% | 12.06B | ||
| +1.32% | +2.09% | -11.64% | +12.41% | 11.74B | ||
| -0.95% | 0.00% | +18.72% | +150.00% | 9.03B | ||
| +0.39% | +2.39% | +29.99% | +38.63% | 7.36B | ||
| -0.06% | +2.97% | +38.90% | -18.67% | 7.15B | ||
| +1.30% | +1.17% | +16.08% | +187.41% | 7.2B | ||
| +0.70% | +1.10% | -44.22% | +5.78% | 5.03B | ||
| Average | +0.23% | +0.98% | +7.49% | +61.98% | 14.28B | |
| Weighted average by Cap. | -0.44% | +0.23% | +16.93% | +73.53% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 143M 124M 117M 107M 200M 13.68B 200M 1.4B 542M 6.96B 536M 524M 22.38B | 36.17M 31.49M 29.73M 27.01M 50.6M 3.47B 50.83M 356M 137M 1.76B 136M 133M 5.67B |
| Net income | 77.98M 67.89M 64.08M 58.22M 109M 7.48B 110M 766M 296M 3.8B 293M 286M 12.23B | 2.29M 1.99M 1.88M 1.71M 3.2M 220M 3.22M 22.51M 8.69M 112M 8.6M 8.41M 359M |
| Net Debt | -0.09 -0.08 -0.08 -0.07 -0.13 -8.82 -0.13 -0.9 -0.35 -4.49 -0.35 -0.34 -14.43 | -0.77 -0.67 -0.64 -0.58 -1.08 -74.21 -1.09 -7.61 -2.94 -37.74 -2.91 -2.84 -121.41 |
Employees
90
Sector
Pharmaceuticals
- Stock Market
- Stocks
- 1SKF401E Stock
Select your edition
All financial news and data tailored to specific country editions
















